Hims & Hers Health, Inc. (NYSE:HIMS) CFO Oluyemi Okupe Sells 11,581 Shares

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CFO Oluyemi Okupe sold 11,581 shares of the firm's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $29.26, for a total transaction of $338,860.06. Following the transaction, the chief financial officer now directly owns 124,104 shares in the company, valued at $3,631,283.04. The trade was a 8.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Oluyemi Okupe also recently made the following trade(s):

• On Monday, February 10th, Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock. The shares were sold at an average price of $43.01, for a total value of $498,098.81.
• On Tuesday, February 4th, Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock. The shares were sold at an average price of $38.92, for a total value of $450,732.52.
• On Monday, January 13th, Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock. The stock was sold at an average price of $24.44, for a total value of $283,039.64.

Hims & Hers Health Stock Performance

NYSE:HIMS traded up $3.29 during mid-day trading on Wednesday, hitting $29.39. 34,775,224 shares of the company's stock traded hands, compared to its average volume of 14,994,666. The company has a market cap of $6.53 billion, a PE ratio of 66.80 and a beta of 1.65. The firm's 50 day simple moving average is $39.29 and its 200 day simple moving average is $30.23. Hims & Hers Health, Inc. has a 1 year low of $11.20 and a 1 year high of $72.98.

Remove Ads

Hims & Hers Health (NYSE:HIMS - Get Free Report) last issued its quarterly earnings data on Monday, February 24th. The company reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.02. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. The business had revenue of $481.14 million during the quarter, compared to analysts' expectations of $494.56 million. On average, research analysts expect that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Truist Financial upped their price objective on shares of Hims & Hers Health from $24.00 to $39.00 and gave the stock a "hold" rating in a research report on Wednesday, February 26th. Bank of America increased their target price on Hims & Hers Health from $21.00 to $22.00 and gave the stock an "underperform" rating in a research note on Tuesday, March 18th. Piper Sandler upped their price objective on Hims & Hers Health from $24.00 to $35.00 and gave the stock a "neutral" rating in a report on Tuesday, February 25th. Needham & Company LLC raised their target price on Hims & Hers Health from $31.00 to $61.00 and gave the company a "buy" rating in a report on Tuesday, February 25th. Finally, BTIG Research started coverage on shares of Hims & Hers Health in a research note on Tuesday, January 7th. They set a "buy" rating and a $35.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $37.31.

Hedge Funds Weigh In On Hims & Hers Health

A number of institutional investors have recently made changes to their positions in the stock. Crewe Advisors LLC purchased a new stake in Hims & Hers Health during the 4th quarter worth about $28,000. Raleigh Capital Management Inc. grew its stake in Hims & Hers Health by 1,100.0% during the fourth quarter. Raleigh Capital Management Inc. now owns 1,200 shares of the company's stock worth $29,000 after buying an additional 1,100 shares during the period. Blume Capital Management Inc. increased its holdings in Hims & Hers Health by 100.0% in the 4th quarter. Blume Capital Management Inc. now owns 1,200 shares of the company's stock valued at $29,000 after purchasing an additional 600 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in shares of Hims & Hers Health by 4,415.6% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the company's stock valued at $36,000 after buying an additional 1,413 shares during the period. Finally, Summit Securities Group LLC acquired a new position in shares of Hims & Hers Health during the fourth quarter worth $38,000. 63.52% of the stock is owned by institutional investors and hedge funds.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.